Healthcare - Medical - Devices - NASDAQ - US
$ 5.95
-7.32 %
$ 766 M
Market Cap
-74.37
P/E
INCOME STATEMENT
193 M
REVENUE
-27.8 M
OPERATING INCOME
-12.1 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Cytek Biosciences, Inc.
| Revenue | 193 M |
| Cost Of Revenue | 83.6 M |
| Gross Profit | 109 M |
| Operating Expenses | 137 M |
| Operating Income | -27.8 M |
| Other Expenses | -15.7 M |
| Net Income | -12.1 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 193.0 | 164.0 | 128.0 | 92.8 | 57.9 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 83.6 | 63.1 | 48.8 | 41.1 | 29.2 |
| Gross Profit | 109.4 | 101.0 | 79.1 | 51.7 | 28.7 |
| OPERATING INCOME | |||||
| Operating Expenses | 137.3 | 102.8 | 70.0 | 38.1 | 25.9 |
| Selling, General and Administrative Expenses | 91.6 | 67.9 | 45.5 | 24.4 | 17.0 |
| Research and Development Expenses | 44.2 | 34.9 | 24.4 | 13.7 | 8.9 |
| Operating Income | (27.8) | (1.8) | 6.4 | 13.7 | 3.7 |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 2.1 | 2.6 | 1.7 | 0.3 | 1 K |
| Total Other Income | 12.1 | 3.1 | (3.2) | 0.8 | 1.0 |
| Pre-Tax Income | (15.7) | 1.3 | 5.9 | 14.4 | (16.3) |
| NET INCOME | |||||
| Tax Provision | (3.6) | (1.2) | 1.5 | (5.0) | 0.5 |
| Net Income | (12.1) | 2.6 | 4.4 | 19.4 | (16.8) |
| EPS | 0.0898 | 0.0192 | 0.033 | 0.0242 | 0.13 |